PLCC full form in medical is Primary liver cell carcinoma. PLCC also known as hepatocellular carcinoma (HCC) is a type of cancer that begins in the liver cells. The liver is a vital organ in the body responsible for several essential functions such as filtering the blood, processing nutrients, and detoxifying harmful substances. When liver cells start to grow uncontrollably, they form a tumor which can be cancerous. People who have chronic liver diseases such as hepatitis B or C, liver cirrhosis, or nonalcoholic fatty liver disease are at higher risk of developing PLCC. Additionally, factors such as excessive alcohol consumption, exposure to aflatoxins, and a family history of liver cancer can also increase the risk.
The symptoms of PLCC may include pain in the abdomen, weight loss, loss of appetite, nausea, and jaundice. Sometimes, a person may not experience any symptoms until cancer has progressed to an advanced stage. Doctors usually diagnose PLCC using imaging tests such as ultrasound, CT scan, or MRI. A biopsy is usually performed to confirm the diagnosis. Early detection is critical for successful treatment and better outcomes. People with a higher risk of developing PLCC should undergo regular screening tests to detect cancer early.